R Hein Selected Research

R Hein Research Topics

Disease

13	Melanoma (Melanoma, Malignant) 01/2021 - 11/2000
5	Neoplasms (Cancer) 05/2016 - 01/2001
3	Chronic Urticaria 01/2002 - 01/2001
2	Stroke (Strokes) 12/2013 - 05/2005
2	Breast Neoplasms (Breast Cancer) 01/2012 - 12/2011
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2010 - 02/2007
2	Neoplasm Metastasis (Metastasis) 11/2005 - 11/2000
2	Pruritus (Itching) 01/2002 - 01/2001
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Fever (Fevers) 05/2016
1	Febrile Neutropenia 05/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2016
1	Neutropenia 05/2016
1	Invasive Fungal Infections 05/2016
1	Femoral Fractures (Femoral Fracture) 01/2015
1	Ischemic Stroke 12/2013
1	Cerebral Infarction 12/2013
1	Lymphatic Metastasis 12/2011
1	Hypertension (High Blood Pressure) 09/2010
1	Coronary Disease (Coronary Heart Disease) 09/2010
1	Diabetes Mellitus 09/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2010
1	Obesity 09/2010
1	Hyperlipoproteinemias 09/2010
1	Localized Scleroderma (Morphea) 02/2010
1	Mental Retardation, Skeletal Dysplasia, and Abducens Palsy 12/2007
1	Vasculitis (Vasculitides) 12/2007
1	Pseudolymphoma 04/2007
1	Necrosis 02/2007
1	Pain (Aches) 04/2006
1	Actinic Keratosis 04/2006
1	Uveal melanoma 11/2005
1	Granuloma 08/2005
1	Atrial Fibrillation 05/2005
1	Scleredema Adultorum 03/2005
1	Pyoderma Gangrenosum 10/2002
1	Erythema 10/2002
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2002
1	Photophobia (Light Sensitivity) 10/2002
1	Urticaria (Hives) 01/2002
1	Circulating Neoplastic Cells 03/2001

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 02/2007 - 11/2000
4	EnzymesIBA 01/2012 - 03/2001
4	Biomarkers (Surrogate Marker)IBA 11/2005 - 11/2000
3	desloratadine (Aerius)FDA LinkGeneric 01/2002 - 01/2001
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2003 - 03/2001
2	ImmunosorbentsIBA 09/2003 - 03/2001
2	Messenger RNA (mRNA)IBA 03/2001 - 01/2001
2	Tumor Biomarkers (Tumor Markers)IBA 01/2001 - 11/2000
1	Immune Checkpoint InhibitorsIBA 01/2021
1	NivolumabIBA 01/2018
1	IpilimumabIBA 01/2018
1	AzolesIBA 05/2016
1	mahuang-tangIBA 01/2012
1	Estrogens (Estrogen)FDA Link 01/2012
1	Hormones (Hormone)IBA 01/2012
1	Progestins (Progestagens)IBA 01/2012
1	Progesterone FDA LinkGeneric 01/2012
1	Epidermal Growth Factor (EGF)IBA 12/2011
1	Genetic Markers (Genetic Marker)IBA 12/2011
1	Monoclonal AntibodiesIBA 07/2011
1	Nicotine FDA Link 09/2010
1	Infliximab (Remicade)FDA Link 12/2007
1	Etanercept (Enbrel)FDA Link 02/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2006
1	Aminolevulinic Acid (Levulan)FDA Link 04/2006
1	Interleukin-5 (Interleukin 5)IBA 08/2005
1	Warfarin (Coumadin)FDA LinkGeneric 05/2005
1	Cadherins (E-Cadherin)IBA 05/2005
1	Extracellular Matrix ProteinsIBA 09/2003
1	Laminin (Merosin)IBA 09/2003
1	Hyaluronic Acid (Hyaluronan)IBA 09/2003
1	laminin 1IBA 09/2003
1	TenascinIBA 09/2003
1	Collagen Type VIIBA 09/2003
1	Biological ProductsIBA 05/2003
1	AntioxidantsIBA 10/2002
1	Platelet-Derived Growth FactorIBA 10/2002
1	Urocanic AcidIBA 10/2002
1	AutoantibodiesIBA 01/2002
1	Immunoglobulin E (IgE)IBA 01/2002
1	ThymidineIBA 08/2001
1	Monophenol Monooxygenase (Tyrosinase)IBA 03/2001
1	Interleukin-2 (IL2)IBA 01/2001
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2001
1	VaccinesIBA 01/2001

Therapy/Procedure

7	Therapeutics 05/2016 - 11/2000
2	Drug Therapy (Chemotherapy) 05/2016 - 01/2001
2	Patient Readmission 01/2015 - 12/2013
2	Phototherapy (Light Therapy) 02/2010 - 03/2005
1	Induction Chemotherapy 05/2016
1	Length of Stay 12/2013
1	Aftercare (After-Treatment) 12/2010
1	Tattooing 04/2007
1	Photochemotherapy (Photodynamic Therapy) 04/2006
1	Duration of Therapy 01/2001
1	Injections 01/2001